Takeda Moves Takhzyro Toward Dominant Position In Pediatric HAE

 
• By Alaric DeArment
  
Takeda presented data from the Phase III SPRING study in hereditary angioedema • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immunological

More from Therapeutic Category